Clinical study to evaluate the safety, efficacy, resource utilization and costs associated with the use of the GORE® TAG® Adaptive Thoracic Stent Graft with ACTIVE CONTROL System for patients with descending thoracic aortic pathologies
INV. INDEP SANITARY PRODUCT CLINIC.
Clinical trial information
- Promoter: ENDOVASCULAR FOUNDATION
- Execution start: 06/07/2020
- End of execution: 30/12/2024
- IP: LUIS MIGUEL SALMERON FEBRES